King L B, Ashwell J D
National Cancer Institute, National Institutes of Health, Bethesda.
Curr Opin Immunol. 1993 Jun;5(3):368-73. doi: 10.1016/0952-7915(93)90055-w.
The induction of programmed cell death in lymphocytes is a common response to a wide variety of physiological and pharmacological stimuli. While there is still much to be learned about the transmembrane signals that lead to programmed cell death, progress has been made in identifying new cell surface molecules (e.g. APO-1/Fas) that may regulate the physiological induction of lymphocyte death, molecules whose expression inhibits apoptosis (e.g. Bcl-2), and the antagonism of activation-induced cell death in T-cell hybridomas and thymocytes by members of the steroid receptor superfamily.
淋巴细胞中程序性细胞死亡的诱导是对多种生理和药理刺激的常见反应。虽然对于导致程序性细胞死亡的跨膜信号仍有许多有待了解之处,但在鉴定可能调节淋巴细胞死亡生理诱导的新细胞表面分子(如APO-1/Fas)、其表达抑制细胞凋亡的分子(如Bcl-2)以及类固醇受体超家族成员对T细胞杂交瘤和胸腺细胞中激活诱导的细胞死亡的拮抗作用方面已经取得了进展。